Evidence map›Paper›PMID 25078778›Full record

ArticlePLoS genetics2014

Distribution and medical impact of loss-of-function variants in the Finnish founder population.

Elaine T Lim, Peter Würtz, Aki S Havulinna, Priit Palta, Taru Tukiainen, Karola Rehnström, Tõnu Esko, Reedik Mägi, Michael Inouye, Tuuli Lappalainen and 51 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 245 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 7 pooled it
1.1field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 7 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Cytosine base editing of LPA in transgenic mice averts large deletions.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

61 authors at 20 institutions in 8 countries.

Elaine T LimAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, United States of America.
Peter WürtzInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.
Aki S HavulinnaDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Priit PaltaInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Taru TukiainenAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Karola RehnströmWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Tõnu EskoProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Estonian Genome Center, University of Tartu, Tartu, Estonia; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Children's Hospital Boston, Boston, Massachusetts, United States of America.
Reedik MägiEstonian Genome Center, University of Tartu, Tartu, Estonia.
Michael InouyeMedical Systems Biology, Department of Pathology and Department of Microbiology & Immunology, The University of Melbourne, Parkville, Victoria, Australia.
Tuuli LappalainenDepartment of Genetics, Stanford University, Stanford, California, United States of America; Stanford Center for Computational, Evolutionary and Human Genomics, Stanford, California, United States of America.
Yingleong ChanProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, United States of America; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Children's Hospital Boston, Boston, Massachusetts, United States of America.
Rany M SalemProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Children's Hospital Boston, Boston, Massachusetts, United States of America.
Monkol LekAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Jason FlannickProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Xueling SimDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, United States of America.
Alisa ManningProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.
Claes LadenvallInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Lund University Diabetes Center, Department of Clinical Sciences, Diabetes & Endocrinology, Skåne University Hospital, Lund University, Malmö, Sweden.
Suzannah BumpsteadWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Eija HämäläinenInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Kristiina AaltoMediCity, University of Turku, Turku, Finland.
Mikael MaksimowMediCity, University of Turku, Turku, Finland.
Marko SalmiDepartment of Medical Microbiology and Immunology, University of Turku and National Institute for Health and Welfare, Turku, Finland.
Stefan BlankenbergUniversity Heart Centre Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
Diego ArdissinoDivision of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Svati ShahDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Benjamin HorneIntermountain Heart Institute, Intermountain Medical Center, Salt Lake City, Utah, United States of America.
Ruth McPhersonDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Gerald K HovinghDepartment of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Muredach P ReillyCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Hugh WatkinsDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Anuj GoelDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Martin FarrallDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Domenico GirelliUniversity of Verona School of Medicine, Department of Medicine, Verona, Italy.
Alex P ReinerDepartment of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Nathan O StitzielCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Sekar KathiresanCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Stacey GabrielProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.
Jeffrey C BarrettWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories, University of Tampere School of Medicine, Tampere, Finland.
Markku LaaksoDepartment of Medicine, University of Eastern Finland, Kuopio, Finland.
Leif GroopInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Lund University Diabetes Center, Department of Clinical Sciences, Diabetes & Endocrinology, Skåne University Hospital, Lund University, Malmö, Sweden.
Jaakko KaprioInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; University of Helsinki, Hjelt Institute, Dept of Public Health, Helsinki, Finland; National Institute for Health and Welfare, Dept of Mental Health and Substance Abuse Services, Helsinki, Finland.
Markus PerolaInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Mark I McCarthyOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Headington, Oxford, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Headington, Oxford, United Kingdom.
Michael BoehnkeDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, United States of America.
David M AltshulerProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Cecilia M LindgrenAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Joel N HirschhornProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Children's Hospital Boston, Boston, Massachusetts, United States of America.
Andres MetspaluEstonian Genome Center, University of Tartu, Tartu, Estonia.
Nelson B FreimerUniversity of California Los Angeles Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California, United States of America.
Tanja ZellerUniversity Heart Centre Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
Sirpa JalkanenDepartment of Medical Microbiology and Immunology, University of Turku and National Institute for Health and Welfare, Turku, Finland.
Seppo KoskinenDepartment of Health, Functional Capacity and Welfare, National Institute for Health and Welfare, Helsinki, Finland.
Olli RaitakariResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
Richard DurbinWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Daniel G MacArthurAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Veikko SalomaaDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Samuli RipattiInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; University of Helsinki, Hjelt Institute, Dept of Public Health, Helsinki, Finland; Department of Biometry, Hjelt Institute, University of Helsinki, Helsinki, Finland.
Mark J DalyAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Aarno PalotieAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Sequencing Initiative Suomi (SISu) Project
Finnish Institute for Health and Welfare · FIWellcome Sanger Institute · GBBroad Institute · USCentre for Human Genetics · GBUniversity of Tartu · EEUniversity of Turku · FIAcademic Medical Center · NLDuke Medical Center · USInstitute for Molecular Medicine Finland · FIIntermountain Medical Center · USMassachusetts General Hospital · USMichigan United · USOspedale di Parma · ITTampere University · FITurku University Hospital · FIUniversity of California, Los Angeles · USUniversity of Eastern Finland · FIUniversity of Melbourne · AUUniversity of Michigan–Ann Arbor · USUniversity of Ottawa · CA

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Low-Pass Sequencing and High-Density SNP Genotyping for Type 2 DiabetesRC2DK088389 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALTSHULER, DAVID, BOEHNKE, MICHAEL L · 2009 to 2010
$17.9M
Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsUC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2010 to 2010
$14.7M
Northwest Genomics CenterUC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2010 to 2010
$14.0M
Cell Interactions in the Inflamed Intestinal MucosaR01DK075787 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI JOEL N HIRSCHHORN · 2007 to 2026
$13.1M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Northwest Genomics CenterRC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2009 to 2009
$11.0M
Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsRC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2009 to 2009
$10.2M
Identifying Genes for Type 2 Diabetes:FUSIONR01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2003 to 2025
$6.7M
Identifying T2D Variants by DNA Sequencing in Multiethnic SamplesU01DK085584 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABECASIS, GONCALO, BOEHNKE, MICHAEL L · 2009 to 2013
$4.1M
Genomic and Metabolomic Profiling of Finnish Familial Dyslipidemia FamiliesR01HL113315 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B., PALOTIE, AARNO · 2012 to 2016
$3.4M
Identifying variants causal for Type 2 Diabetes in Major human populationsU01DK085545 · NIDDK · UNIVERSITY OF OXFORD · PI CHAN, JULIANA CN, EBRAHIM, SHAH BRIAN · 2009 to 2013
$2.8M
NHLBI NIH HHS HL-102926NHLBI NIH HHS HL-103010NHLBI NIH HHS R01 HL113315NHLBI NIH HHS RC2 HL102923NHLBI NIH HHS RC2 HL102924NHLBI NIH HHS RC2 HL-102925NHLBI NIH HHS RC2 HL102925NHLBI NIH HHS RC2 HL102926NHLBI NIH HHS RC2 HL103010NHLBI NIH HHS RFA-HL-12-007NHLBI NIH HHS UC2 HL102923NHLBI NIH HHS UC2 HL102924NHLBI NIH HHS UC2 HL102925NHLBI NIH HHS UC2 HL102926NHLBI NIH HHS UC2 HL103010NIDDK NIH HHS DK062370NIDDK NIH HHS DK085584NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK062370NIDDK NIH HHS R01 DK075787NIDDK NIH HHS R01DK075787NIDDK NIH HHS R56 DK062370NIDDK NIH HHS RC2 DK088389NIDDK NIH HHS RC2-DK088389NIDDK NIH HHS U01 DK062370NIDDK NIH HHS U01 DK085545NIDDK NIH HHS U01-DK-085545NIDDK NIH HHS U01 DK085584Wellcome TrustWellcome Trust 086596/Z/08/ZWellcome Trust 090367Wellcome Trust 098381
6 · The paper itself

Abstract

Exome sequencing studies in complex diseases are challenged by the allelic heterogeneity, large number and modest effect sizes of associated variants on disease risk and the presence of large numbers of neutral variants, even in phenotypically relevant genes. Isolated populations with recent bottlenecks offer advantages for studying rare variants in complex diseases as they have deleterious variants that are present at higher frequencies as well as a substantial reduction in rare neutral variation. To explore the potential of the Finnish founder population for studying low-frequency (0.5-5%) variants in complex diseases, we compared exome sequence data on 3,000 Finns to the same number of non-Finnish Europeans and discovered that, despite having fewer variable sites overall, the average Finn has more low-frequency loss-of-function variants and complete gene knockouts. We then used several well-characterized Finnish population cohorts to study the phenotypic effects of 83 enriched loss-of-function variants across 60 phenotypes in 36,262 Finns. Using a deep set of quantitative traits collected on these cohorts, we show 5 associations (p<5×10⁻⁸) including splice variants in LPA that lowered plasma lipoprotein(a) levels (P = 1.5×10⁻¹¹⁷). Through accessing the national medical records of these participants, we evaluate the LPA finding via Mendelian randomization and confirm that these splice variants confer protection from cardiovascular disease (OR = 0.84, P = 3×10⁻⁴), demonstrating for the first time the correlation between very low levels of LPA in humans with potential therapeutic implications for cardiovascular diseases. More generally, this study articulates substantial advantages for studying the role of rare variation in complex phenotypes in founder populations like the Finns and by combining a unique population genetic history with data from large population cohorts and centralized research access to National Health Registers.

Indexed as

Founder EffectGenetic Diseases, InbornGenetic DriftGenetics, PopulationExomeFemaleFinlandGene FrequencyGenetic VariationGenome-Wide Association StudyHumansMalePhenotypeWhite People

Identifiers

PMID25078778
PMCPMC4117444
OpenAlexW1584484141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.